CDEK by Data4ThePeople
Sign in Sign up
← Mechanisms of action

CEACAM5

SINGLE PROTEINHomo sapiens
Preferred name: Carcinoembryonic antigen-related cell adhesion molecule 5 ChEMBL ↗

Linked proteins

Drugs acting on this target (72)

Active Pharmaceutical Ingredient Mechanism Type ▲ Approval Status API Type Mechanism of Action
m9140AntagonistexperimentalmAbCEACAM5
111in-imp-288Binding agentexperimentalPeptideCEACAM5 binding agent
A5B7Binding agentexperimentalmAbcarcinoembryonic antigen
amg 211Binding agentexperimentalmAbCEACAM5 binding agent
anti-ceaxanti-dtpa bispecific antibodyBinding agentexperimentalmAbCEACAM5 binding agent
Arcitumomab (cea-scan)Binding agentapprovedmAbCEACAM5 binding agent
ba1202Binding agentexperimentalmAbCEACAM5 binding agent
bgb-b167Binding agentexperimentalmAbCEACAM5 binding agent
di-dtpa-131iBinding agentexperimentalmAbCEACAM5 binding agent
ebc-129Binding agentexperimentalmAbCEACAM5 binding agent
F6Binding agentexperimentalmAbCEACAM5 binding agent
IVP ZCE 025Binding agentexperimentalmAbCEACAM5 binding agent
labetuzumab govitecanBinding agentexperimentalmAbCEACAM5 binding agent
sar408701Binding agentexperimentalmAbCarcinoembryonic antigen-related cell adhesion molecule 5 binding agent
sgn-ceacam5cBinding agentexperimentalmAbCEACAM5 binding agent
t84.66Binding agentexperimentalmAbCEACAM5 binding agent
medi-565Cross-linking agentexperimentalmAbCEACAM5 cross-linking agent
ad-cea vaccineImmunity, activeexperimentalVaccineCEACAM5 immunity, active
alvac-cea vaccineImmunity, activeexperimentalVaccineCEACAM5 immunity, active
alvac-cea-b7.1 vaccineImmunity, activeexperimentalVaccineCEACAM5 immunity, active
avx701Immunity, activeexperimentalVaccineCEACAM5 immunity, active
cap1-6dImmunity, activeexperimentalVaccineCEACAM5 immunity, active
carcinoembryonic antigen peptide 1Immunity, activeexperimentalBiologicalCEACAM5 immunity, active
carcinoembryonic antigen-expressing measles virusImmunity, activeexperimentalVaccineCEACAM5 immunity, active
cea peptide 1-6dImmunity, activeexperimentalVaccineCEACAM5 immunity, active
cea-loaded dendritic cellsImmunity, activeexperimentalVaccineCEACAM5 immunity, active
cv301Immunity, activeexperimentalVaccineCEACAM5 immunity, active
etbx-011Immunity, activeexperimentalVaccineCEACAM5 immunity, active
falimarevImmunity, activeexperimentalVaccineCEACAM5 immunity, active
gi-6207Immunity, activeexperimentalBiologicalCEACAM5 immunity, active
MN-14Immunity, activeexperimentalmAbCEACAM5 immunity, active
recombinant fowlpox-cea(6d)/tricom vaccineImmunity, activeexperimentalVaccineCEACAM5 immunity, active
rv-cea(6d)/tricomImmunity, activeexperimentalVaccineCEACAM5 immunity, active
triadeno vaccineImmunity, activeexperimentalVaccineCEACAM5 immunity, active
tricom-cea(6d)Immunity, activeexperimentalVaccineCEACAM5 immunity, active
vaccinia-cea vaccineImmunity, activeexperimentalVaccineCEACAM5 immunity, active
vaccinia-cea(6d)-tricom vaccineImmunity, activeexperimentalVaccineCEACAM5 immunity, active
3h1Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
89zr-amg211Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
90Yttrium-labelled Anti-CD66 Monoclonal AntibodyImmunity, passiveexperimentalmAbCEACAM5 immunity, passive
a2b530Immunity, passiveexperimentalCell therapyCEACAM5 immunity, passive
anti-cea designer t cellsImmunity, passiveexperimentalCell therapyCEACAM5 immunity, passive
Arcitumomab (cea-scan)Immunity, passiveapprovedmAbCEACAM5 immunity, passive
cea car-t cellsImmunity, passiveexperimentalCell therapyCEACAM5 immunity, passive
cea gene modified t cellsImmunity, passiveexperimentalCell therapyCEACAM5 immunity, passive
cergutuzumab amunaleukinImmunity, passiveexperimentalmAbCEACAM5 immunity, passive
cibisatamabImmunity, passiveexperimentalmAbCEACAM5 immunity, passive
cu 64 m5aImmunity, passiveexperimentalmAbCEACAM5 immunity, passive
imp288Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
in111 imp-205xm734Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
in111 monoclonal antibody mn-14Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
mfe23 scfv-expressing autologous anti-cea mfez t lymphocytesImmunity, passiveexperimentalCell therapyCEACAM5 immunity, passive
mg7-cartImmunity, passiveexperimentalCell therapyCEACAM5 immunity, passive
monoclonal antibody hmn-14Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
pg13-cea_tcrImmunity, passiveexperimentalCell therapyCEACAM5 immunity, passive
ro6895882Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
sgm-101Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
t84.66Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
y90 dota anti-cea monoclonal antibody m5aImmunity, passiveexperimentalmAbCEACAM5 immunity, passive
y90 monoclonal antibody mn-14Immunity, passiveexperimentalmAbCEACAM5 immunity, passive
altumomabInhibitorexperimentalmAbCEACAM5 inhibitor
bms-986490InhibitorexperimentalmAbCEACAM5 inhibitor
cibisatamabInhibitorexperimentalmAbCEACAM5 inhibitor
ibi3004InhibitorexperimentalmAbCEACAM5 inhibitor
ibi3020InhibitorexperimentalmAbCEACAM5 inhibitor
lm-24c5InhibitorexperimentalmAbCEACAM5 inhibitor
medi-565InhibitorexperimentalmAbCEACAM5 inhibitor
nilk-2301InhibitorexperimentalmAbCEACAM5 inhibitor
ro7172508InhibitorexperimentalmAbCEACAM5 inhibitor
sar408701InhibitorexperimentalmAbCEACAM5 inhibitor
tf2InhibitorexperimentalmAbCEACAM5 inhibitor
monoclonal antibody hmn-14OtherexperimentalmAbCEACAM5 other